慢性冠動脈症候群の管理のためのEACTSと協力して開発されたESCガイドラインにおける侵襲的な治療戦略:現代の臨床実践への影響
Milan Milojevic1, Slobodan Micovic1,2, Petar Otasevic3,2
1Department of Cardiac Surgery and Cardiovascular Research.
Current opinion in cardiology
|September 3, 2025
まとめ
慢性冠動脈症候群 (CCS) に関する2024年のESCガイドラインは,皮膚経冠動脈介入 (PCI) や冠動脈バイパス移植 (CABG) などの再血管化戦略に対する心臓チームによる決定を優先して治療アプローチを統一しています. 処置の詳細と二次予防については,さらなる指針が必要である.
科学分野:
- 心臓病科
- 介入心臓科
- 心血管外科
背景:
- 慢性冠動脈症候群 (CCS) の管理には,最新のガイドラインが必要です.
- 以前のガイドラインでは 侵襲的な治療法の選択に 統一されたアプローチが欠けていたかもしれません
研究 の 目的:
- CCSに関する2024年欧州心臓学会 (ESC) のガイドラインを批判的に評価する.
- 侵襲的な治療の推奨,根拠,実施のギャップに焦点を当てます.
主な方法:
- CCSのための2024 ESCガイドラインのレビューと批判的評価
- 心筋再循環と再循環方式の選択に関する勧告の分析
主要な成果:
- ガイドラインは,皮膚経冠動脈介入 (PCI) と冠動脈バイパス移植 (CABG) の指示を単一のCCSの枠組みに統合しています.
- Heart-Teamの決定は,解剖学的複雑性,SYNTAXスコア,および併発性に基づいた基準で,同様に推奨される戦略を強調しています.
- CABGは,複雑な疾患 (例えば,左主,多血管) に好ましいが,PCIは,症状の緩和または高リスクの患者に適しています.
- 処置の詳細,二次予防,最適な介入タイミングに関するガイドラインは限られている.
結論:
- 2024年ガイドラインは,CCS管理に対する統一された欧州のアプローチを確立しています.
- ガイドラインによる再血管化と心臓チームによる意思決定が再確認されています.
- 方法論的側面,二次予防,実施に関する補足的な指導が必要である.
さらに関連する動画
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
3.7K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.4K
関連する概念動画
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:26Acute Coronary Syndrome V: Nursing Management
37
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
37
01:26Angina IV: Management
22
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
22
01:30Acute Coronary Syndrome I: Introduction
71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71